Business Context and Reporting Period
Company: Delcath Systems, Inc. (DCTH)
Filing Type: Form 8-K (Current Report)
Report Date: August 6, 2026
Reporting Period: Quarter ended June 30, 2026
Context: This filing announces the issuance of a press release containing financial results and business highlights for the second quarter of 2026.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) but does not contain specific numerical data. Consequently, the following metrics are not available in this filing text:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to the referenced press release (Exhibit 99.1) for this information.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the release of business highlights but does not include the specific commentary, guidance, or outlook within the text of the 8-K itself.
Risks and Contingencies: No specific risks or contingencies are detailed in this document.
Unusual Items: None identified in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 6, 2026) for actual financial figures, as they are not embedded in the 8-K text.
- Verify the specific revenue and net income figures for the quarter ended June 30, 2026, against prior periods.
- Check for any updated forward-looking guidance or clinical trial milestones mentioned in the press release.
- Confirm the company's cash position and runway based on the detailed financial statements referenced in the press release.